89bio, Inc.
Overview
89bio, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies to address liver and cardio-metabolic diseases. The company aims to improve the lives of patients with serious and life-threatening conditions by advancing its product candidates through clinical development.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to 89bio, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this 89bio, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.